These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 9275531)
1. [Gene expression of HGF and its receptor in experimental hepatomas]. Luo Y; Wu M; Chen H Zhonghua Yi Xue Za Zhi; 1996 Nov; 76(11):822-5. PubMed ID: 9275531 [TBL] [Abstract][Full Text] [Related]
2. Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma. Tuck AB; Park M; Sterns EE; Boag A; Elliott BE Am J Pathol; 1996 Jan; 148(1):225-32. PubMed ID: 8546209 [TBL] [Abstract][Full Text] [Related]
3. Relationship between the proliferative capability of hepatocytes and the intrahepatic expression of hepatocyte growth factor and c-Met in the course of cirrhosis development in rats. Inoue H; Yokoyama F; Kita Y; Yoshiji H; Tsujimoto T; Deguchi A; Nakai S; Morishita A; Uchida N; Masaki T; Watanabe S; Kuriyama S Int J Mol Med; 2006 May; 17(5):857-64. PubMed ID: 16596271 [TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma. Price JA; Kovach SJ; Johnson T; Koniaris LG; Cahill PA; Sitzmann JV; McKillop IH Hepatology; 2002 Nov; 36(5):1089-97. PubMed ID: 12395318 [TBL] [Abstract][Full Text] [Related]
5. Ontogeny of hepatocyte growth factor and c-met/hgf receptor in rat pancreas. Calvo EL; Boucher C; Pelletier G; Morisset J Biochem Biophys Res Commun; 1996 Dec; 229(1):257-63. PubMed ID: 8954115 [TBL] [Abstract][Full Text] [Related]
6. Amplification and overexpression of the hepatocyte growth factor receptor (HGFR/MET) in rat DMBA sarcomas. Helou K; Wallenius V; Qiu Y; Ohman F; Ståhl F; Klinga-Levan K; Kindblom LG; Mandahl N; Jansson JO; Levan G Oncogene; 1999 May; 18(21):3226-34. PubMed ID: 10359528 [TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor and c-met expression in Long-Evans Cinnamon rats with spontaneous hepatitis and hepatoma. Nakayama N; Kashiwazaki H; Kobayashi N; Hamada JI; Ogiso Y; Itakura Y; Matsumoto K; Nakamura T; Koike T; Kuzumaki N; Takeichi N Hepatology; 1996 Sep; 24(3):596-602. PubMed ID: 8781331 [TBL] [Abstract][Full Text] [Related]
8. Hepatocyte growth factor receptor in human RPE cells: implications in proliferative vitreoretinopathy. Lashkari K; Rahimi N; Kazlauskas A Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):149-56. PubMed ID: 9888438 [TBL] [Abstract][Full Text] [Related]
9. Presence of phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor progression and survival in patients with conventional renal cell carcinoma. Miyata Y; Kanetake H; Kanda S Clin Cancer Res; 2006 Aug; 12(16):4876-81. PubMed ID: 16914575 [TBL] [Abstract][Full Text] [Related]
10. Expression of hepatocyte growth factor and its receptor c-met, correlates with severity of pathological injury in experimental alcoholic liver disease. Lalani el-N; Poulsom R; Stamp G; Fogt F; Thomas P; Nanji AA Int J Mol Med; 2005 May; 15(5):811-7. PubMed ID: 15806303 [TBL] [Abstract][Full Text] [Related]
11. Effect of hepatocyte growth factor on cell cycle and c-met expression in human gastric cancer cells. Liu SI; Lui WY; Mok KT; Wu CW; Chi CW Anticancer Res; 1997; 17(5A):3575-80. PubMed ID: 9413205 [TBL] [Abstract][Full Text] [Related]
12. Expression of hepatocyte growth factor and c-Met after spinal cord injury in rats. Shimamura M; Sato N; Sata M; Wakayama K; Ogihara T; Morishita R Brain Res; 2007 Jun; 1151():188-94. PubMed ID: 17425951 [TBL] [Abstract][Full Text] [Related]
13. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma]. Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653 [TBL] [Abstract][Full Text] [Related]
14. Hepatocyte growth factor and c-Met expression in rat and human liver fibrosis. Cramer T; Schuppan D; Bauer M; Pfander D; Neuhaus P; Herbst H Liver Int; 2004 Aug; 24(4):335-44. PubMed ID: 15287857 [TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine. Horiguchi N; Takayama H; Toyoda M; Otsuka T; Fukusato T; Merlino G; Takagi H; Mori M Oncogene; 2002 Mar; 21(12):1791-9. PubMed ID: 11896611 [TBL] [Abstract][Full Text] [Related]
16. Adenoviral-mediated gene expression of hepatocyte growth factor prevents postoperative peritoneal adhesion in a rat model. Liu HJ; Wu CT; Duan HF; Wu B; Lu ZZ; Wang L Surgery; 2006 Sep; 140(3):441-7. PubMed ID: 16934607 [TBL] [Abstract][Full Text] [Related]
18. c-Met responsiveness of isolated hepatocytes evaluated in an in vitro de-differentiation model. Boost KA; Kim HJ; Engl T; Oppermann E; Jonas D; Oertl A; Blaheta RA Int J Mol Med; 2006 Mar; 17(3):475-82. PubMed ID: 16465395 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of epidermal growth factor and hepatocyte growth factor receptors in a proportion of gastrinomas correlates with aggressive growth and lower curability. Peghini PL; Iwamoto M; Raffeld M; Chen YJ; Goebel SU; Serrano J; Jensen RT Clin Cancer Res; 2002 Jul; 8(7):2273-85. PubMed ID: 12114431 [TBL] [Abstract][Full Text] [Related]
20. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma. Fieten H; Spee B; Ijzer J; Kik MJ; Penning LC; Kirpensteijn J Vet Pathol; 2009 Sep; 46(5):869-77. PubMed ID: 19429984 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]